The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Open accessAbstract
The review aims to consolidate research findings on the molecular mechanisms and virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and their relevance to four typical stages in the development of acute viral infection. These four stages are invasion; primary blockade of antiviral innate immunity; engagement of the virus’s protection mechanisms against the factors of adaptive immunity; and acute, long-term complications of COVID-19. The invasion stage entails the recognition of the spike protein (S) of SARS-CoV-2 target cell receptors, namely, the main receptor (angiotensin-converting enzyme 2, ACE2), its coreceptors, and potential alternative receptors. The presence of a diverse repertoire of receptors allows SARS-CoV-2 to infect various types of cells, including those not expressing ACE2. During the second stage, the majority of the polyfunctional structural, non-structural, and extra proteins SARS-CoV-2 synthesizes in infected cells are involved in the primary blockage of antiviral innate immunity. A high degree of redundancy and systemic action characterizing these pathogenic factors allows SARS-CoV-2 to overcome antiviral mechanisms at the initial stages of invasion. The third stage includes passive and active protection of the virus from factors of adaptive immunity, overcoming of the barrier function at the focus of inflammation, and generalization of SARS-CoV-2 in the body. The fourth stage is associated with the deployment of variants of acute and long-term complications of COVID-19. SARS-CoV-2’s ability to induce autoimmune and autoinflammatory pathways of tissue invasion and development of both immunosuppressive and hyperergic mechanisms of systemic inflammation is critical at this stage of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32656-8 · Cited by 4,084
RetractedA new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688 · cited 2×
“The long incubation period and the presence of asymptomatic variants of COVID-19, as well as the high level of contagiousness and transmissibility, make the identification, tracking, and elimination of this disease challenging [27,28].”
BackgroundCryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
Characteristics of SARS-CoV-2 and COVID-19
Hu, B., Guo, H., Zhou, P., & Shi, Z.-L. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00459-7 · Cited by 5,291
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528 · cited 1×
“The spread of new mutations in the S-protein can potentially reduce the effectiveness of the immune response to vaccines [57].”
BackgroundNextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,062
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science · doi:10.1126/science.abd4585 · Cited by 2,662
Huang, Y., Yang, C., Xu, X.-F., Xu, W., & Liu, S.-W. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0485-4 · Cited by 2,224
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Coronavirus Disease 2019–COVID-19
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,876
Karki, R., Sharma, B. R., Tuladhar, S., Williams, E. P., Zalduondo, L., Samir, P., Zheng, M., Sundaram, B., Banoth, B., Malireddi, R. K. S., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.025 · Cited by 1,734
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
Tan, L., Wang, Q., Zhang, D., Ding, J., Huang, Q., Tang, Y.-Q., Wang, Q., & Miao, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0148-4 · Cited by 1,690
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Wang, K., Chen, W., Zhang, Z., Deng, Y., Lian, J.-Q., Du, P., Wei, D., Zhang, Y., Sun, X.-X., Gong, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00426-x · Cited by 1,593
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., et al. (2020) · eLife · doi:10.7554/elife.61312 · Cited by 1,308 · cited 1×
“The presence of numerous mutations in the S-protein also indicates the ability of the spike protein to acquire new properties of ligand specificity [73].”
BackgroundOmicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
Karim, S. S. A., & Karim, Q. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02758-6 · Cited by 1,226
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Petersen, E., Koopmans, M., Go, U., Hamer, D. H., Petrosillo, N., Castelli, F., Storgaard, M., Al Khalili, S., & Simonsen, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30484-9 · Cited by 1,205
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Harrison, A. G., Lin, T., & Wang, P. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.004 · Cited by 1,186
Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Clausen, T. M., Sandoval, D. R., Spliid, C. B., Pihl, J., Perrett, H. R., Painter, C. D., Narayanan, A., Majowicz, S. A., Kwong, E. M., McVicar, R. N., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.033 · Cited by 1,136
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
Wang, F., Nie, J., Wang, H., Zhao, Q., Xiong, Y., Deng, L., Song, S., Ma, Z., Mo, P., & Zhang, Y. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa150 · Cited by 1,131
Hosts and Sources of Endemic Human Coronaviruses
Corman, V. M., Muth, D., Niemeyer, D., & Drosten, C. (2018) · Advances in Virus Research · doi:10.1016/bs.aivir.2018.01.001 · Cited by 995
Evasion of Type I Interferon by SARS-CoV-2
Xia, H., Cao, Z., Xie, X., Zhang, X., Chen, J. Y.-C., Wang, H., Menachery, V. D., Rajsbaum, R., & Shi, P.-Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108234 · Cited by 957
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034545 · Cited by 940
Raveendran, A. V., Jayadevan, R., & Sashidharan, S. (2021) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2021.04.007 · Cited by 921
Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909
2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
Daffis, S., Szretter, K. J., Schriewer, J., Li, J., Youn, S., Errett, J., Lin, T.-Y., Schneller, S., Zust, R., Dong, H., et al. (2010) · Nature · doi:10.1038/nature09489 · Cited by 907
Qi, F., Qian, S., Zhang, S., & Zhang, Z. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.044 · Cited by 905
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
Thoms, M., Buschauer, R., Ameismeier, M., Koepke, L., Denk, T., Hirschenberger, M., Kratzat, H., Hayn, M., Mackens-Kiani, T., Cheng, J., et al. (2020) · Science · doi:10.1126/science.abc8665 · Cited by 881
Rodrigues, T. S., de Sá, K. S. G., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Gonçalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201707 · Cited by 839 · cited 1×
“Furthermore, SARS‐direct CoV‐2’s impact on the nod‐ like‐receptor (NLR) and secondary changes in intracellular homeostasis induce viral‐non‐ specific cellular stress pathways in diverse cells, such as NF‐κB activation and NLRP3 inflammasome assembly [131,132].”
BackgroundT cell responses in patients with COVID-19
Chen, Z., & John Wherry, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0402-6 · Cited by 797 · cited 2×
“additional causes of IL‐6 and IL‐10 overproduction may be detected [247,248].”
BackgroundCircuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
Grant, R. A., Morales-Nebreda, L., Markov, N. S., Swaminathan, S., Querrey, M., Guzman, E. R., Abbott, D. A., Donnelly, H. K., Donayre, A., Goldberg, I. A., et al. (2021) · Nature · doi:10.1038/s41586-020-03148-w · Cited by 727
Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies
Dani, M., Dirksen, A., Taraborrelli, P., Torocastro, M., Panagopoulos, D., Sutton, R., & Lim, P. B. (2021) · Clinical Medicine · doi:10.7861/clinmed.2020-0896 · Cited by 721
GRP78: A cell's response to stress
Ibrahim, I. M., Abdelmalek, D. H., & Elfiky, A. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.022 · Cited by 647
The role of IgG Fc receptors in antibody-dependent enhancement
Bournazos, S., Gupta, A., & Ravetch, J. V. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00410-0 · Cited by 617
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Renia, L., & Remuzzi, G. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 607
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., Thomas, W. D., Thackray, L. B., Young, M. D., Mason, R. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403812101 · Cited by 605
SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses
Banerjee, A. K., Blanco, M. R., Bruce, E. A., Honson, D. D., Chen, L. M., Chow, A., Bhat, P., Ollikainen, N., Quinodoz, S. A., Loney, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.004 · Cited by 583
Acter, T., Uddin, N., Das, J., Akhter, A., Choudhury, T. R., & Kim, S. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138996 · Cited by 575
Nieto-Torres, J. L., DeDiego, M. L., Verdiá-Báguena, C., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Fernandez-Delgado, R., Castaño-Rodriguez, C., Alcaraz, A., Torres, J., Aguilella, V. M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004077 · Cited by 559
Ehrenfeld, M., Tincani, A., Andreoli, L., Cattalini, M., Greenbaum, A., Kanduc, D., Alijotas-Reig, J., Zinserling, V., Semenova, N., Amital, H., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102597 · Cited by 559
Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms
Smatti, M. K., Cyprian, F. S., Nasrallah, G. K., Al Thani, A. A., Almishal, R. O., & Yassine, H. M. (2019) · Viruses · doi:10.3390/v11080762 · Cited by 544
Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306446101 · Cited by 543
ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis
Simões e Silva, A., Silveira, K., Ferreira, A., & Teixeira, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12159 · Cited by 542
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
Zhang, Y., Chen, Y., Li, Y., Huang, F., Luo, B., Yuan, Y., Xia, B., Ma, X., Yang, T., Yu, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024202118 · Cited by 535
Romano, M., Ruggiero, A., Squeglia, F., Maga, G., & Berisio, R. (2020) · Cells · doi:10.3390/cells9051267 · Cited by 527
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Miorin, L., Kehrer, T., Sanchez-Aparicio, M. T., Zhang, K., Cohen, P., Patel, R. S., Cupic, A., Makio, T., Mei, M., Moreno, E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016650117 · Cited by 527
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
Yuen, C.-K., Lam, J.-Y., Wong, W.-M., Mak, L.-F., Wang, X., Chu, H., Cai, J.-P., Jin, D.-Y., To, K. K.-W., Chan, J. F.-W., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1780953 · Cited by 524
Morris, S. B., Schwartz, N. G., Patel, P., Abbo, L., Beauchamps, L., Balan, S., Lee, E. H., Paneth-Pollak, R., Geevarughese, A., Lash, M. K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6940e1 · Cited by 523
Siu, K., Yuen, K., Castano‐Rodriguez, C., Ye, Z., Yeung, M., Fung, S., Yuan, S., Chan, C., Yuen, K., Enjuanes, L., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802418r · Cited by 502
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
Pan, P., Shen, M., Yu, Z., Ge, W., Chen, K., Tian, M., Xiao, F., Wang, Z., Wang, J., Jia, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25015-6 · Cited by 501
Wang, S., Qiu, Z., Hou, Y., Deng, X., Xu, W., Zheng, T., Wu, P., Xie, S., Bian, W., Zhang, C., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00460-y · Cited by 499
Malik, Y. S., Sircar, S., Bhat, S., Sharun, K., Dhama, K., Dadar, M., Tiwari, R., & Chaicumpa, W. (2020) · Veterinary Quarterly · doi:10.1080/01652176.2020.1727993 · Cited by 498
Choudhury, A., & Mukherjee, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25987 · Cited by 488
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
Klemm, T., Ebert, G., Calleja, D. J., Allison, C. C., Richardson, L. W., Bernardini, J. P., Lu, B. G., Kuchel, N. W., Grohmann, C., Shibata, Y., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020106275 · Cited by 485
COVID-19 and autoimmune diseases
Liu, Y., Sawalha, A. H., & Lu, Q. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000776 · Cited by 476
Mutations Strengthened SARS-CoV-2 Infectivity
Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.07.009 · Cited by 466
Host Immune Response to Influenza A Virus Infection
Chen, X., Liu, S., Goraya, M. U., Maarouf, M., Huang, S., & Chen, J.-L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00320 · Cited by 462
Lu, S., Ye, Q., Singh, D., Cao, Y., Diedrich, J. K., Yates, J. R., Villa, E., Cleveland, D. W., & Corbett, K. D. (2021) · Nature Communications · doi:10.1038/s41467-020-20768-y · Cited by 462
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
Osipiuk, J., Azizi, S.-A., Dvorkin, S., Endres, M., Jedrzejczak, R., Jones, K. A., Kang, S., Kathayat, R. S., Kim, Y., Lisnyak, V. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21060-3 · Cited by 462
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
Li, J.-Y., Liao, C.-H., Wang, Q., Tan, Y.-J., Luo, R., Qiu, Y., & Ge, X.-Y. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198074 · Cited by 461
Chen, Y., Cai, H., Pan, J., Xiang, N., Tien, P., Ahola, T., & Guo, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808790106 · Cited by 457
COVID-19-associated coagulopathy and disseminated intravascular coagulation
Asakura, H., & Ogawa, H. (2021) · International Journal of Hematology · doi:10.1007/s12185-020-03029-y · Cited by 442
Is COVID-19 receiving ADE from other coronaviruses?
Tetro, J. A. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.02.006 · Cited by 434
Gram-positive toxic shock syndromes
Lappin, E., & Ferguson, A. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70066-0 · Cited by 433
Konno, Y., Kimura, I., Uriu, K., Fukushi, M., Irie, T., Koyanagi, Y., Sauter, D., Gifford, R. J., Nakagawa, S., & Sato, K. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108185 · Cited by 433
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors
Onomoto, K., Onoguchi, K., & Yoneyama, M. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00602-7 · Cited by 430
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Wang, S.-F., Tseng, S.-P., Yen, C.-H., Yang, J.-Y., Tsao, C.-H., Shen, C.-W., Chen, K.-H., Liu, F.-T., Liu, W.-T., Chen, Y.-M. A., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.090 · Cited by 421
Autoimmune and inflammatory diseases following COVID-19
Galeotti, C., & Bayry, J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0448-7 · Cited by 402
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Ji, H.-L., Zhao, R., Matalon, S., & Matthay, M. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00013.2020 · Cited by 399
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
Liu, W. J., Zhao, M., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 395
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., O’Meara, M. J., Guo, J. Z., Swaney, D. L., Tummino, T. A., Huettenhain, R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.22.002386 · Cited by 395
Cheng, M. H., Zhang, S., Porritt, R. A., Noval Rivas, M., Paschold, L., Willscher, E., Binder, M., Arditi, M., & Bahar, I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010722117 · Cited by 393
Crystal structure of Nsp15 endoribonuclease NendoU from SARS‐CoV ‐2
Kim, Y., Jedrzejczak, R., Maltseva, N. I., Wilamowski, M., Endres, M., Godzik, A., Michalska, K., & Joachimiak, A. (2020) · Protein Science · doi:10.1002/pro.3873 · Cited by 384
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
Cagno, V., Tseligka, E. D., Jones, S. T., & Tapparel, C. (2019) · Viruses · doi:10.3390/v11070596 · Cited by 376
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375
Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways
Zevini, A., Olagnier, D., & Hiscott, J. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.12.004 · Cited by 368
Mycroft-West, C. J., Su, D., Pagani, I., Rudd, T. R., Elli, S., Gandhi, N. S., Guimond, S. E., Miller, G. J., Meneghetti, M. C. Z., Nader, H. B., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1721319 · Cited by 361
Li, J., Guo, M., Tian, X., Wang, X., Yang, X., Wu, P., Liu, C., Xiao, Z., Qu, Y., Yin, Y., et al. (2021) · Med · doi:10.1016/j.medj.2020.07.002 · Cited by 360
Miao, G., Zhao, H., Li, Y., Ji, M., Chen, Y., Shi, Y., Bi, Y., Wang, P., & Zhang, H. (2021) · Developmental Cell · doi:10.1016/j.devcel.2020.12.010 · Cited by 354 · cited 2×
“ Oxidative stress [134,135]; Autophagy and lysosomal stress [136,137]; Ubiquitination of proteins; this process is important for the regulation of function and proteolysis of many intracellular proteins [138]; Mitochondrial stress, in particular, is dependent on the RLR/MAVS signaling path‐ way [139]; Endopla…”
BackgroundSARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
Jiang, H.-W., Zhang, H.-N., Meng, Q.-F., Xie, J., Li, Y., Chen, H., Zheng, Y.-X., Wang, X.-N., Qi, H., Zhang, J., et al. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0514-8 · Cited by 351
Torjesen, I. (2021) · BMJ · doi:10.1136/bmj.n2943 · Cited by 348
Aboudounya, M. M., & Heads, R. J. (2021) · Mediators of Inflammation · doi:10.1155/2021/8874339 · Cited by 346
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Zhang, Q., Xiang, R., Huo, S., Zhou, Y., Jiang, S., Wang, Q., & Yu, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00653-w · Cited by 339
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Amraei, R., Yin, W., Napoleon, M. A., Suder, E. L., Berrigan, J., Zhao, Q., Olejnik, J., Chandler, K. B., Xia, C., Feldman, J., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01537 · Cited by 337
The case of complement activation in COVID-19 multiorgan impact
Noris, M., Benigni, A., & Remuzzi, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.013 · Cited by 335
A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease
PrabhuDas, M. R., Baldwin, C. L., Bollyky, P. L., Bowdish, D. M. E., Drickamer, K., Febbraio, M., Herz, J., Kobzik, L., Krieger, M., Loike, J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700373 · Cited by 329
A Potential Role of Interleukin 10 in COVID-19 Pathogenesis
Lu, L., Zhang, H., Dauphars, D. J., & He, Y.-W. (2021) · Trends in Immunology · doi:10.1016/j.it.2020.10.012 · Cited by 329
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Zamorano Cuervo, N., & Grandvaux, N. (2020) · eLife · doi:10.7554/elife.61390 · Cited by 313
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Rodríguez, Y., Novelli, L., Rojas, M., De Santis, M., Acosta-Ampudia, Y., Monsalve, D. M., Ramírez-Santana, C., Costanzo, A., Ridgway, W. M., Ansari, A. A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102506 · Cited by 312
Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review
Suhail, S., Zajac, J., Fossum, C., Lowater, H., McCracken, C., Severson, N., Laatsch, B., Narkiewicz-Jodko, A., Johnson, B., Liebau, J., et al. (2020) · The Protein Journal · doi:10.1007/s10930-020-09935-8 · Cited by 306
Zheng, Y., Zhuang, M.-W., Han, L., Zhang, J., Nan, M.-L., Zhan, P., Kang, D., Liu, X., Gao, C., & Wang, P.-H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00438-7 · Cited by 302
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
Vanderheiden, A., Ralfs, P., Chirkova, T., Upadhyay, A. A., Zimmerman, M. G., Bedoya, S., Aoued, H., Tharp, G. M., Pellegrini, K. L., Manfredi, C., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00985-20 · Cited by 301
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
Redondo, N., Zaldívar-López, S., Garrido, J. J., & Montoya, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708264 · Cited by 299
Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
Au-Yeung, N., Mandhana, R., & Horvath, C. M. (2013) · JAK-STAT · doi:10.4161/jkst.23931 · Cited by 296
An aberrant STAT pathway is central to COVID-19
Matsuyama, T., Kubli, S. P., Yoshinaga, S. K., Pfeffer, K., & Mak, T. W. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-00633-7 · Cited by 289
Yan, L., Ge, J., Zheng, L., Zhang, Y., Gao, Y., Wang, T., Huang, Y., Yang, Y., Gao, S., Li, M., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.016 · Cited by 289
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Ramasamy, S., & Subbian, S. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00299-20 · Cited by 289
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry
Wei, C., Wan, L., Yan, Q., Wang, X., Zhang, J., Yang, X., Zhang, Y., Fan, C., Li, D., Deng, Y., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00324-0 · Cited by 287
Omicron variant and booster COVID-19 vaccines
Burki, T. K. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00559-2 · Cited by 285
Hasan, S. S., Capstick, T., Ahmed, R., Kow, C. S., Mazhar, F., Merchant, H. A., & Zaidi, S. T. R. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1804365 · Cited by 283
Moustaqil, M., Ollivier, E., Chiu, H.-P., Van Tol, S., Rudolffi-Soto, P., Stevens, C., Bhumkar, A., Hunter, D. J. B., Freiberg, A. N., Jacques, D., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1870414 · Cited by 283
COVID-19: Characteristics and Therapeutics
Chilamakuri, R., & Agarwal, S. (2021) · Cells · doi:10.3390/cells10020206 · Cited by 282
Peng, Q., Peng, R., Yuan, B., Zhao, J., Wang, M., Wang, X., Wang, Q., Sun, Y., Fan, Z., Qi, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107774 · Cited by 277
Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein
(2020) · doi:10.1073/pnas.2021785118 · Cited by 274
Ramaswamy, A., Brodsky, N. N., Sumida, T. S., Comi, M., Asashima, H., Hoehn, K. B., Li, N., Liu, Y., Shah, A., Ravindra, N. G., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.003 · Cited by 271
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Brant, A. C., Tian, W., Majerciak, V., Yang, W., & Zheng, Z.-M. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00643-z · Cited by 270
The interferon landscape along the respiratory tract impacts the severity of COVID-19
Sposito, B., Broggi, A., Pandolfi, L., Crotta, S., Clementi, N., Ferrarese, R., Sisti, S., Criscuolo, E., Spreafico, R., Long, J. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.016 · Cited by 269
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection
Hachim, A., Kavian, N., Cohen, C. A., Chin, A. W. H., Chu, D. K. W., Mok, C. K. P., Tsang, O. T. Y., Yeung, Y. C., Perera, R. A. P. M., Poon, L. L. M., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0773-7 · Cited by 267
Wu, J., Shi, Y., Pan, X., Wu, S., Hou, R., Zhang, Y., Zhong, T., Tang, H., Du, W., Wang, L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108761 · Cited by 265
Minakshi, R., Padhan, K., Rani, M., Khan, N., Ahmad, F., & Jameel, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008342 · Cited by 257
Benvenuto, D., Angeletti, S., Giovanetti, M., Bianchi, M., Pascarella, S., Cauda, R., Ciccozzi, M., & Cassone, A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.058 · Cited by 255
Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium, Zhang, F., Mears, J. R., Shakib, L., Beynor, J. I., Shanaj, S., Korsunsky, I., Nathan, A., Donlin, L. T., & Raychaudhuri, S. (2021) · Genome Medicine · doi:10.1186/s13073-021-00881-3 · Cited by 249
Han, L., Zhuang, M., Deng, J., Zheng, Y., Zhang, J., Nan, M., Zhang, X., Gao, C., & Wang, P. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27050 · Cited by 245
Costenbader, K. H., Gay, S., Alarcón-Riquelme, M. E., Iaccarino, L., & Doria, A. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.10.022 · Cited by 241
Kim, M.-J., Hwang, S.-Y., Imaizumi, T., & Yoo, J.-Y. (2008) · Journal of Virology · doi:10.1128/jvi.01650-07 · Cited by 238
Treating Human Autoimmunity: Current Practice and Future Prospects
Rosenblum, M. D., Gratz, I. K., Paw, J. S., & Abbas, A. K. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003504 · Cited by 237
Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2
Rehman, S. U., Shafique, L., Ihsan, A., & Liu, Q. (2020) · Pathogens · doi:10.3390/pathogens9030240 · Cited by 237
Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2
Nielsen, S. C. A., Yang, F., Jackson, K. J. L., Hoh, R. A., Röltgen, K., Jean, G. H., Stevens, B. A., Lee, J.-Y., Rustagi, A., Rogers, A. J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.09.002 · Cited by 236
Structural basis of RNA cap modification by SARS-CoV-2
Viswanathan, T., Arya, S., Chan, S.-H., Qi, S., Dai, N., Misra, A., Park, J.-G., Oladunni, F., Kovalskyy, D., Hromas, R. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17496-8 · Cited by 231
The role of extracellular vesicles in COVID-19 virus infection
Hassanpour, M., Rezaie, J., Nouri, M., & Panahi, Y. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104422 · Cited by 226
Autoinflammation and autoimmunity: Bridging the divide
Doria, A., Zen, M., Bettio, S., Gatto, M., Bassi, N., Nalotto, L., Ghirardello, A., Iaccarino, L., & Punzi, L. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.018 · Cited by 225
Rha, M.-S., Jeong, H. W., Ko, J.-H., Choi, S. J., Seo, I.-H., Lee, J. S., Sa, M., Kim, A. R., Joo, E.-J., Ahn, J. Y., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.002 · Cited by 225
Winter of Omicron—The Evolving COVID-19 Pandemic
del Rio, C., Omer, S. B., & Malani, P. N. (2022) · JAMA · doi:10.1001/jama.2021.24315 · Cited by 213
MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner
Fang, R., Jiang, Q., Zhou, X., Wang, C., Guan, Y., Tao, J., Xi, J., Feng, J.-M., & Jiang, Z. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006720 · Cited by 210
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63432-0.00003-7 · Cited by 202
Omicron variant genome evolution and phylogenetics
Kandeel, M., Mohamed, M. E. M., Abd El‐Lateef, H. M., Venugopala, K. N., & El‐Beltagi, H. S. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27515 · Cited by 202
Hatmal, M. M., Alshaer, W., Al-Hatamleh, M. A. I., Hatmal, M., Smadi, O., Taha, M. O., Oweida, A. J., Boer, J. C., Mohamud, R., & Plebanski, M. (2020) · Cells · doi:10.3390/cells9122638 · Cited by 196
Mechanisms of MAVS Regulation at the Mitochondrial Membrane
Jacobs, J. L., & Coyne, C. B. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.007 · Cited by 195
Xia, B., Shen, X., He, Y., Pan, X., Liu, F.-L., Wang, Y., Yang, F., Fang, S., Wu, Y., Duan, Z., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00519-4 · Cited by 194
Porritt, R. A., Paschold, L., Rivas, M. N., Cheng, M. H., Yonker, L. M., Chandnani, H., Lopez, M., Simnica, D., Schultheiß, C., Santiskulvong, C., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146614 · Cited by 190
Mechanism of Nucleic Acid Unwinding by SARS-CoV Helicase
Adedeji, A. O., Marchand, B., te Velthuis, A. J. W., Snijder, E. J., Weiss, S., Eoff, R. L., Singh, K., & Sarafianos, S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036521 · Cited by 189
Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections
Hilleman, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404758101 · Cited by 187
COVID‐19 and Immunological Dysregulation: Can Autoantibodies be Useful?
Pascolini, S., Vannini, A., Deleonardi, G., Ciordinik, M., Sensoli, A., Carletti, I., Veronesi, L., Ricci, C., Pronesti, A., Mazzanti, L., et al. (2021) · Clinical and Translational Science · doi:10.1111/cts.12908 · Cited by 187
Characterization of accessory genes in coronavirus genomes
Michel, C. J., Mayer, C., Poch, O., & Thompson, J. D. (2020) · Virology Journal · doi:10.1186/s12985-020-01402-1 · Cited by 180
Abu-Raddad, L. J., Chemaitelly, H., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Ayoub, H. H., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1846 · Cited by 180
Mielech, A. M., Chen, Y., Mesecar, A. D., & Baker, S. C. (2014) · Virus Research · doi:10.1016/j.virusres.2014.01.025 · Cited by 179
TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection
de Marcken, M., Dhaliwal, K., Danielsen, A. C., Gautron, A. S., & Dominguez-Villar, M. (2019) · Science Signaling · doi:10.1126/scisignal.aaw1347 · Cited by 179
Moreno-Eutimio, M. A., López-Macías, C., & Pastelin-Palacios, R. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.04.009 · Cited by 178
The role of Neuropilin-1 in COVID-19
Mayi, B. S., Leibowitz, J. A., Woods, A. T., Ammon, K. A., Liu, A. E., & Raja, A. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009153 · Cited by 178
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids
Sun, J., Xiao, J., Sun, R., Tang, X., Liang, C., Lin, H., Zeng, L., Hu, J., Yuan, R., Zhou, P., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2608.201097 · Cited by 174
Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms
Jafarzadeh, A., Jafarzadeh, S., Nozari, P., Mokhtari, P., & Nemati, M. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12967 · Cited by 174
Carlos, A. J., Ha, D. P., Yeh, D.-W., Van Krieken, R., Tseng, C.-C., Zhang, P., Gill, P., Machida, K., & Lee, A. S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100759 · Cited by 172
Busnadiego, I., Fernbach, S., Pohl, M. O., Karakus, U., Huber, M., Trkola, A., Stertz, S., & Hale, B. G. (2020) · mBio · doi:10.1128/mbio.01928-20 · Cited by 170
Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications
Kočar, E., Režen, T., & Rozman, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158849 · Cited by 169
Ou, J., Zhou, Z., Dai, R., Zhang, J., Zhao, S., Wu, X., Lan, W., Ren, Y., Cui, L., Lan, Q., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00617-21 · Cited by 169
Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins
Gorkhali, R., Koirala, P., Rijal, S., Mainali, A., Baral, A., & Bhattarai, H. K. (2021) · Bioinformatics and Biology Insights · doi:10.1177/11779322211025876 · Cited by 169
Moreews, M., Gouge, K. L., Khaldi-Plassart, S., Pescarmona, R., Mathieu, A., Malcus, C., Djebali, S., Bellomo, A., Dauwalder, O., Perret, M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abh1516 · Cited by 164
DC-SIGN and L-SIGN: the SIGNs for infection
Khoo, U.-S., Chan, K. Y. K., Chan, V. S. F., & Lin, C. L. S. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0350-2 · Cited by 162
Interactions of SARS-CoV-2 with the Blood–Brain Barrier
Erickson, M. A., Rhea, E. M., Knopp, R. C., & Banks, W. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052681 · Cited by 162
Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects
Alouf, J. E., & Müller-Alouf, H. (2003) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00232 · Cited by 161
The structural basis of accelerated host cell entry by SARS‐CoV‐2†
Seyran, M., Takayama, K., Uversky, V. N., Lundstrom, K., Palù, G., Sherchan, S. P., Attrish, D., Rezaei, N., Aljabali, A. A. A., Ghosh, S., et al. (2021) · The FEBS Journal · doi:10.1111/febs.15651 · Cited by 159
Peng, R., Wu, L.-A., Wang, Q., Qi, J., & Gao, G. F. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.06.001 · Cited by 159
COVID-19: Complement, Coagulation, and Collateral Damage
Lo, M. W., Kemper, C., & Woodruff, T. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000644 · Cited by 158
Fink, K., & Grandvaux, N. (2013) · JAK-STAT · doi:10.4161/jkst.27521 · Cited by 157
The Role of Th17 Response in COVID-19
Martonik, D., Parfieniuk‐Kowerda, A., Rogalska, M., & Flisiak, R. (2021) · Cells · doi:10.3390/cells10061550 · Cited by 156
The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children
Porritt, R. A., Binek, A., Paschold, L., Rivas, M. N., McArdle, A., Yonker, L. M., Alter, G., Chandnani, H. K., Lopez, M., Fasano, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151520 · Cited by 156
Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients
Hu, Z., Xu, J. M., Yin, J., Li, L., Hou, W., Zhang, L., Zhou, Z., Yu, Y., Li, H., Feng, Y., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585647 · Cited by 155
Lymphopenia Caused by Virus Infections and the Mechanisms Beyond
Guo, Z., Zhang, Z., Prajapati, M., & Li, Y. (2021) · Viruses · doi:10.3390/v13091876 · Cited by 155
Deng, X., & Baker, S. C. (2018) · Virology · doi:10.1016/j.virol.2017.12.024 · Cited by 153
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Gadanec, L. K., McSweeney, K. R., Qaradakhi, T., Ali, B. A., Zulli, A., & Apostolopoulos, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030992 · Cited by 153
Gray, J. I., Westerhof, L. M., & MacLeod, M. K. L. (2018) · Immunology · doi:10.1111/imm.12929 · Cited by 152
Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus
Bakhshandeh, B., Jahanafrooz, Z., Abbasi, A., Goli, M. B., Sadeghi, M., Mottaqi, M., & Zamani, M. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104831 · Cited by 150
Characterization of the SARS‐CoV ‐2 E Protein: Sequence, Structure, Viroporin, and Inhibitors
Cao, Y., Yang, R., Lee, I., Zhang, W., Sun, J., Wang, W., & Meng, X. (2021) · Protein Science · doi:10.1002/pro.4075 · Cited by 150
Extracellular vesicles are the Trojan horses of viral infection
Altan‐Bonnet, N. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.004 · Cited by 148
Troya, J., Bastard, P., Planas‐Serra, L., Ryan, P., Ruíz, M., de Carranza, M., Torres‐Macho, J., Martínez, A., Abel, L., Casanova, J., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01036-0 · Cited by 148
Rationale for targeting complement in COVID‐19
Polycarpou, A., Howard, M. C., Farrar, C. A., Greenlaw, R., Fanelli, G., Wallis, R., Klavinskis, L. S., & Sacks, S. H. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012642 · Cited by 145
Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes
Zhou, Z., Huang, C., Zhou, Z., Huang, Z., Su, L., Kang, S., Chen, X., Chen, Q., He, S., Xia, R., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102187 · Cited by 143
Multi-level inhibition of coronavirus replication by chemical ER stress
Shaban, M. S., Müller, C., Mayr‐Buro, C., Weiser, H., Meier‐Soelch, J., Albert, B. V., Weber, A., Linne, U., Hain, T., Babayev, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25551-1 · Cited by 140
Dengue Fever, COVID ‐19 ( SARS‐CoV ‐2), and Antibody‐Dependent Enhancement ( ADE ): A Perspective
Ulrich, H., Pillat, M. M., & Tárnok, A. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24047 · Cited by 139
ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway
Lin, X., Fu, B., Yin, S., Li, Z., Liu, H., Zhang, H., Xing, N., Wang, Y., Xue, W., Xiong, Y., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102293 · Cited by 138
Inflammasome formation in the lungs of patients with fatal COVID-19
Toldo, S., Bussani, R., Nuzzi, V., Bonaventura, A., Mauro, A. G., Cannatà, A., Pillappa, R., Sinagra, G., Nana-Sinkam, P., Sime, P., et al. (2021) · Inflammation Research · doi:10.1007/s00011-020-01413-2 · Cited by 132
Kim, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124549 · Cited by 132
Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock
Krakauer, T. (2019) · Toxins · doi:10.3390/toxins11030178 · Cited by 131
Heras, N. D. L., Giménez, V. M. M., Ferder, L., Manucha, W. A., & Lahera, V. (2020) · Antioxidants · doi:10.3390/antiox9090897 · Cited by 131
Oh, S. J., & Shin, O. S. (2021) · Cells · doi:10.3390/cells10030530 · Cited by 130
Setti, L., Passarini, F., de Gennaro, G., Barbieri, P., Pallavicini, A., Ruscio, M., Piscitelli, P., Colao, A., & Miani, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17092986 · Cited by 129
SeyedAlinaghi, S., Mirzapour, P., Dadras, O., Pashaei, Z., Karimi, A., MohsseniPour, M., Soleymanzadeh, M., Barzegary, A., Afsahi, A. M., Vahedi, F., et al. (2021) · European journal of medical research · doi:10.1186/s40001-021-00524-8 · Cited by 126
Erratum to “Long COVID: An overview” [Diabetes Metabol. Syndr. Clin. Res. Rev. (2021) 869–875]
Raveendran, A. V., Jayadevan, R., & Sashidharan, S. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102660 · Cited by 123
Rivas, M. N., Porritt, R. A., Cheng, M. H., Bahar, İ., & Arditi, M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.008 · Cited by 122
Kumar, A., Ishida, R., Strilets, T., Cole, J., López-Orozco, J., Fayad, N., Felix-Lopez, A., Elaish, M., Evseev, D., Magor, K. E., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00266-21 · Cited by 122
Kouwaki, T., Nishimura, T., Wang, G., & Oshiumi, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700926 · Cited by 120
Gusev, E., Владимировна, С. Л., Zhuravleva, Y. A., & Sarapultsev, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111453 · Cited by 118
Self-citationMarino, A., Légaré, S., Bosco, G. L., Fucarino, A., Angileri, F., de Macario, E. C., Macario, A. J. L., & Cappello, F. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01148-3 · Cited by 116
Sayed, S. E., Shokry, D., & Gomaa, S. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12154 · Cited by 116
Alquisiras-Burgos, I., Peralta-Arrieta, I., Alonso-Palomares, L. A., Zacapala-Gómez, A. E., Salmerón-Bárcenas, E. G., & Aguilera, P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02134-7 · Cited by 115
Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
dos Santos, W. G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111272 · Cited by 115
Rahimi, N. (2020) · Biology · doi:10.3390/biology10010001 · Cited by 114
Antibody-dependent enhancement of coronavirus
Wen, J., Cheng, Y., Ling, R., Dai, Y., Huang, B., Huang, W., Zhang, S., & Jiang, Y.-Z. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.015 · Cited by 113
Covid-19: Early studies give hope omicron is milder than other variants
Christie, B. (2021) · BMJ · doi:10.1136/bmj.n3144 · Cited by 113
Cranial neuropathies and COVID-19: Neurotropism and autoimmunity
Costello, F., & Dalakas, M. C. (2020) · Neurology · doi:10.1212/wnl.0000000000009921 · Cited by 112
Solanich, X., Rigo-Bonnin, R. F., Gumucio, V. D., Bastard, P., Rosain, J., Philippot, Q., Pérez-Fernández, X. L., Fuset-Cabanes, M. P., Gordillo-Benitez, M., Suárez-Cuartín, G., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01136-x · Cited by 112
Gangaev, A., Ketelaars, S. L. C., Isaeva, O. I., Patiwael, S., Dopler, A., Hoefakker, K., De Biasi, S., Gibellini, L., Mussini, C., Guaraldi, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22811-y · Cited by 111
IκB kinase ɛ (IKKɛ): A therapeutic target in inflammation and cancer
Verhelst, K., Verstrepen, L., Carpentier, I., & Beyaert, R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.007 · Cited by 110
Cited by
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 312
Self-citationHost-directed immunotherapy of viral and bacterial infections: past, present and future
Wallis, R. S., O’Garra, A., Sher, A., & Wack, A. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00734-z · Cited by 255
Metadata
- Authors
- Gusev, E., Sarapultsev, A., Solomatina, L., & Chereshnev, V.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-02-02
- Volume
- 23
- Issue
- 3
- Pages
- 1716
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4210457246
- Cited by
- 281
- References
- 315
- FWCI
- 29.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.